Identifiability of enzyme kinetic parameters in substrate competition: a case study of CD39/NTPDase1

被引:0
|
作者
McGuinness, Anna N. [1 ]
Tahir, Aman [1 ]
Sutton, Nadia R. [1 ,2 ,3 ]
Marquis, Andrew D. [4 ,5 ]
机构
[1] Michigan Med, Dept Med, Div Cardiovasc Med, Ann Arbor, MI USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA
[3] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN USA
[4] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
[5] Appl BioMath, Concord, MA 01742 USA
关键词
Enzyme kinetics; Substrate competition; Parameter estimation; Identifiability; CD39; NTPDase1; Ectonucleotidase; ATP-DIPHOSPHOHYDROLASE; PURIFICATION; HYDROLYSIS;
D O I
10.1007/s11302-023-09942-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD39 (NTPDase1-nucleoside triphosphate diphosphohydrolase 1) is a membrane-tethered ectonucleotidase that hydrolyzes extracellular ATP to ADP and ADP to AMP. This enzyme is expressed in a variety of cell types and tissues and has broadly been recognized within vascular tissue to have a protective role in converting "danger" ligands (ATP) into neutral ligands (AMP). In this study, we investigate the enzyme kinetics of CD39 using a Michaelis-Menten modeling framework. We show how the unique situation of having a reaction product also serving as a substrate (ADP) complicates the determination of the governing kinetic parameters. Model simulations using values for the kinetic parameters reported in the literature do not align with corresponding time-series data. This dissonance is explained by CD39 kinetic parameters previously being determined by graphical/linearization methods, which have been shown to distort the underlying error structure and lead to inaccurate parameter estimates. Modern methods of estimating these kinetic parameters using nonlinear least squares are still challenging due to unidentifiable parameter interactions. We propose a workflow to accurately determine these parameters by isolating the ADPase and ATPase reactions and estimating the respective ADPase parameters and ATPase parameters with independent data sets. Theoretically, this ensures all kinetic parameters are identifiable and reliable for future prospective model simulations involving CD39. These kinds of mathematical models can be used to understand how circulating purinergic nucleotides affect disease etiology and potentially inform the development of corresponding therapies.
引用
收藏
页码:257 / 271
页数:15
相关论文
共 50 条
  • [1] Thrombo-Inflammation: A Focus on NTPDase1/CD39
    Morello, Silvana
    Caiazzo, Elisabetta
    Turiello, Roberta
    Cicala, Carla
    CELLS, 2021, 10 (09)
  • [2] Opposite deregulations of NTPDase1 (CD39) and NTPDase3 by cystic fibrosis
    Picher, Maryse
    Fausther, Michel
    Pelletier, Julie
    Ribeiro, Carla M.
    Sevigny, Jean
    PURINERGIC SIGNALLING, 2010, 6 : 119 - 119
  • [3] Localization of NTPDase1/CD39 in normal and transformed human pancreas
    Kittel, A
    Garrido, M
    Varga, G
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2002, 50 (04) : 549 - 555
  • [4] Insulin-resistance in CD39/NTPDase1 knockout mice
    Enjyoji, K
    Kotani, K
    Thurkal, C
    Csizmadia, E
    Jackson, S
    Kahn, BB
    Robson, SC
    DIABETES, 2004, 53 : A308 - A308
  • [5] NTPDase1/CD39 and aberrant purinergic signalling in the pathogenesis of COPD
    Lazar, Zsofia
    Muellner, Nina
    Lucattelli, Monica
    Ayata, Cemil Korcan
    Cicko, Sanja
    Yegutkin, Gennady G.
    De Cunto, Giovanna
    Mueller, Tobias
    Meyer, Anja
    Hossfeld, Madelon
    Sorichter, Stephan
    Horvath, Ildiko
    Virchow, Christian J.
    Robson, Simon C.
    Lungarella, Giuseppe
    Idzko, Marco
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (01) : 254 - 263
  • [6] NTPDase1 (CD39) controls nucleotide dependent vasomotion in mouse
    Sevigny, Jean
    Kauffenstein, Gilles
    Fuerstenau, Cristina Ribas
    Drouin, Annick
    Thorin-Trescases, Nathalie
    Robaye, Bernard
    D'Orleans-Juste, Pedro
    Marceau, Francois
    Thorin, Eric
    PURINERGIC SIGNALLING, 2010, 6 : 25 - 26
  • [7] NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse
    Kauffenstein, Gilles
    Drouin, Annick
    Thorin-Trescases, Nathalie
    Bachelard, Helene
    Robaye, Bernard
    D'Orleans-Juste, Pedro
    Marceau, Francois
    Thorin, Eric
    Sevigny, Jean
    CARDIOVASCULAR RESEARCH, 2010, 85 (01) : 204 - 213
  • [8] NTPDASE1 (CD39) regulates extracellular nuclecitides-induced vasomotion
    Kauffenstein, G.
    Sevigny, J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 249C - 249C
  • [9] NTPDase1 (cd39) regulates extracellular nucleotides-induced vasomotion
    Kauffenstein, G.
    Sevigny, J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 : 25 - 25
  • [10] Cystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3
    Fausther, Michel
    Pelletier, Julie
    Ribeiro, Carla M.
    Sevigny, Jean
    Picher, Maryse
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2010, 298 (06) : L804 - L818